Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Inventory (2023 - 2026)

Solventum posted quarterly Inventory of $1.1 billion for Q1 2026, up 25.75% year-on-year from $866.0 million in Q1 2025, and up 2.16% on a QoQ basis from $1.1 billion in Q4 2025.

Solventum (SOLV) has 4 years of Inventory data on file, last reported at $1.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Inventory rose 25.75% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 25.75% YoY), and the FY2025 full-year result was $1.1 billion, up 10.47% from the prior year.
  • Inventory for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
  • Across five years, Inventory topped out at $1.1 billion in Q1 2026 and bottomed at $857.0 million in Q4 2023.
  • The 4-year median for Inventory is $957.5 million (2024), against an average of $960.7 million.
  • The widest annual swing landed in 2025, when Inventory retreated 3.88%; it then grew 25.75% in 2026.
  • A 4-year view of Inventory shows it stood at $857.0 million in 2023, then rose by 12.6% to $965.0 million in 2024, then rose by 10.47% to $1.1 billion in 2025, then gained by 2.16% to $1.1 billion in 2026.
  • The last three Inventory figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 1.95 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 3.36 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 911.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 452.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 1.09 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 876.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 214.94 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.32 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 551.48 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 179.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.09 Bn
Dec 31, 2025 1.07 Bn
Sep 30, 2025 1.05 Bn
Jun 30, 2025 962.00 Mn
Mar 31, 2025 866.00 Mn
Dec 31, 2024 965.00 Mn
Sep 30, 2024 953.00 Mn
Jun 30, 2024 899.00 Mn
Mar 31, 2024 901.00 Mn
Dec 31, 2023 857.00 Mn